EP Patent

EP3243524A1 — Activin-actriia antagonists and uses for decreasing or inhibiting fsh secretion

Assigned to Acceleron Pharma Inc · Expires 2017-11-15 · 9y expired

What this patent protects

In certain aspects, the present invention provides compositions and methods for decreasing FSH levels in a patient. The patient may, for example, be diagnosed with an FSH- related disorder or desire to delay or inhibit germ cell maturation.

USPTO Abstract

In certain aspects, the present invention provides compositions and methods for decreasing FSH levels in a patient. The patient may, for example, be diagnosed with an FSH- related disorder or desire to delay or inhibit germ cell maturation.

Drugs covered by this patent

Patent Metadata

Patent number
EP3243524A1
Jurisdiction
EP
Classification
—
Expires
2017-11-15
Drug substance claim
No
Drug product claim
No
Assignee
Acceleron Pharma Inc
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.